Nanning Chemical Industry Co., Ltd. (600301.SS) Bundle
A compact but revealing snapshot: Nanning Chemical Industry reported CN¥4.84 billion in revenue for the fiscal year ending December 31, 2024-a 20.20% year‑over‑year rise-while revenue per share TTM hit CN¥7.66 and gross profit reached CN¥1.91 billion (gross margin ~39.5%) with an operating margin of 24.82%; profitability shows net income attributable to shareholders of CN¥674.26 million (net margin ~13.93%), ROA of 11.41% and ROE of 23.61%, and balance‑sheet metrics include total debt to equity of 30.46%, a current ratio of 1.35 and book value per share of CN¥6.56, complemented by strong cash generation-operating cash flow TTM of CN¥1.11 billion and levered free cash flow of CN¥781.24 million-while valuation multiples as of July 5, 2025 read a trailing P/E of 19.70, forward P/E of 10.56, P/S of CN¥2.68 and P/B of 3.12 (EV/Revenue 2.87; EV/EBITDA 8.72); key risks and opportunities to weigh include only 15% revenue from international sales, ~60% of operating costs tied to ethylene/propylene, reports in 2023 that ~30% of facilities missed emission standards, and sector tailwinds such as a projected $1 trillion sustainable chemicals market by 2030 at an ~11% CAGR-read on to parse what these figures mean for investors.
Nanning Chemical Industry Co., Ltd. (600301.SS) - Revenue Analysis
Nanning Chemical Industry Co., Ltd. reported strong topline growth for the fiscal year ending December 31, 2024, driven by volume expansion and favorable product mix.- Total revenue (FY 2024): CN¥4.84 billion - a 20.20% increase year-over-year.
- Quarterly revenue growth (YoY): 20.20% - indicates consistent sequential sales momentum versus the prior-year quarter.
- Revenue per share (TTM): CN¥7.66 - a key per-share productivity metric that positions the company competitively within the chemical sector.
| Metric | Value | Notes |
|---|---|---|
| Total Revenue (FY 2024) | CN¥4.84 billion | 20.20% YoY growth |
| Revenue Per Share (TTM) | CN¥7.66 | Per-share revenue generation |
| Gross Profit (TTM) | CN¥1.91 billion | Gross profit margin ≈ 39.5% |
| Gross Profit Margin (TTM) | 39.5% | Reflects product mix and raw material cost management |
| Operating Margin (TTM) | 24.82% | Signals efficient operating control |
| Quarterly Revenue Growth (YoY) | 20.20% | Consistent top-line growth |
- Margin context: gross margin ~39.5% and operating margin 24.82% together suggest healthy conversion of revenue into operating profit, leaving room for R&D, capex or dividend policy.
- Per-share metrics: revenue per share CN¥7.66 supports EPS potential when paired with controlled operating costs and favorable margins.
- Growth drivers: volume increases, pricing realization, and product mix improvements are likely contributors to the 20.20% revenue growth.
Nanning Chemical Industry Co., Ltd. (600301.SS) - Profitability Metrics
Nanning Chemical Industry Co., Ltd. (600301.SS) demonstrates robust profitability across multiple key indicators for the trailing twelve months (TTM), reflecting effective cost control, asset utilization, and strong returns to shareholders.
- Net income attributable to common shareholders (TTM): CN¥674.26 million, yielding a net profit margin of ~13.93%.
- Return on assets (ROA, TTM): 11.41% - indicates efficient use of assets to generate profit.
- Return on equity (ROE, TTM): 23.61% - strong returns on shareholders' equity.
- Operating margin (TTM): 24.82% - nearly a quarter of revenue converts to operating profit.
- Industry context: chemical industry average net profit margins typically range from 5% to 15%; Nanning Chemical sits at the upper end of this band.
- Trend note: metrics have been consistent over recent years, indicating stable underlying performance.
| Metric | Value (TTM) | Interpretation |
|---|---|---|
| Net Income to Common Shareholders | CN¥674.26 million | Sustained bottom-line profitability |
| Net Profit Margin | 13.93% | Competitive vs. industry 5%-15% range |
| Operating Margin | 24.82% | High operating leverage and cost control |
| Return on Assets (ROA) | 11.41% | Efficient asset deployment |
| Return on Equity (ROE) | 23.61% | Strong returns for shareholders |
For additional context on corporate priorities and how profitability aligns with strategic direction, see: Mission Statement, Vision, & Core Values (2026) of Nanning Chemical Industry Co., Ltd.
Nanning Chemical Industry Co., Ltd. (600301.SS) - Debt vs. Equity Structure
As of March 31, 2025, key balance-sheet metrics highlight a moderate leverage profile and adequate short-term liquidity for Nanning Chemical Industry Co., Ltd. (600301.SS).- Total debt to equity ratio: 30.46% - indicates moderate use of debt financing relative to shareholder equity.
- Current ratio: 1.35 - suggests the company can cover its short-term liabilities with current assets.
- Book value per share: CN¥6.56 - shows net asset value allocated per outstanding share.
| Metric | Value (as of 2025-03-31) | Comment |
|---|---|---|
| Total debt to equity | 30.46% | Within typical chemical industry range (20%-50%). |
| Current ratio | 1.35 | Adequate liquidity; >1 is generally satisfactory. |
| Book value per share | CN¥6.56 | Useful for comparing against market price for valuation. |
- Leverage: At 30.46%, leverage is moderate and aligns with industry norms, limiting financial risk from excessive borrowing.
- Liquidity: A current ratio of 1.35 supports operational flexibility and short-term obligations coverage.
- Valuation signal: CN¥6.56 book value per share provides a baseline for assessing price-to-book comparisons.
Nanning Chemical Industry Co., Ltd. (600301.SS) Liquidity and Solvency
Nanning Chemical Industry Co., Ltd. (600301.SS) shows solid liquidity and solvency metrics for the trailing twelve months (TTM), with operating cash flow and levered free cash flow indicating healthy cash generation and capacity to meet obligations.- Operating cash flow (TTM): CN¥1.11 billion - robust cash generation from core operations.
- Levered free cash flow (TTM): CN¥781.24 million - cash available after financing costs.
- Current ratio: 1.35 - sufficient short-term assets to cover short-term liabilities.
- Operating cash flow to total debt: ~0.11 - within a healthy range versus peers.
- Levered free cash flow to total debt: ~0.08 - reasonable debt service capacity.
- Industry benchmark (OCF/total debt): 0.05-0.15 - Nanning Chemical sits comfortably inside this band.
| Metric | Value | Interpretation |
|---|---|---|
| Operating Cash Flow (TTM) | CN¥1,110,000,000 | Strong operational cash generation |
| Levered Free Cash Flow (TTM) | CN¥781,240,000 | Available cash after financing obligations |
| Current Ratio | 1.35 | Acceptable short-term liquidity |
| OCF / Total Debt | 0.11 | Within industry-standard range (0.05-0.15) |
| LFCF / Total Debt | 0.08 | Reasonable ability to service debt with free cash |
Nanning Chemical Industry Co., Ltd. (600301.SS) - Valuation Analysis
Nanning Chemical Industry Co., Ltd. (600301.SS) presents a mixed valuation profile as of July 5, 2025, with several metrics pointing toward relative undervaluation versus forward earnings expectations while remaining moderately premium on book value.- Trailing P/E: 19.70 - reflects recent earnings; near the upper-mid range of typical chemical-sector multiples.
- Forward P/E: 10.56 - materially lower than trailing P/E, implying expected earnings growth or one-time recoveries priced in by the market.
- Price-to-Sales (TTM): CN¥2.68 - indicates market values each yuan of sales at ~2.68 yuan.
- Price-to-Book (P/B): 3.12 - market values equity at just over three times book, slightly above industry norms.
- Enterprise Value / Revenue: 2.87 - shows EV relative to top-line; useful when comparing capital structures.
- Enterprise Value / EBITDA: 8.72 - a compressed multiple suggesting attractive valuation on an EV/EBITDA basis.
| Metric | Value | Interpretation |
|---|---|---|
| Trailing P/E (7/5/2025) | 19.70 | Comparable to industry mid-range (15-25) |
| Forward P/E (7/5/2025) | 10.56 | Indicates expected earnings improvement or earnings normalization |
| Price-to-Sales (TTM) | 2.68 | Market pricing of revenue |
| Price-to-Book | 3.12 | Premium to book value; above typical industry 1-3 range |
| EV / Revenue | 2.87 | Moderate enterprise valuation vs. sales |
| EV / EBITDA | 8.72 | Attractive relative to many peers |
| Industry avg P/E | 15-25 | Sector benchmark |
| Industry avg P/B | 1-3 | Sector benchmark |
- Relative positioning: Trailing P/E (~19.7) sits within industry average; forward P/E (~10.6) implies the market expects near-term earnings improvement or reduced one-off charges.
- Capital structure/enterprise view: EV/EBITDA at 8.72 and EV/Revenue at 2.87 signal that on an enterprise basis the company is valued attractively versus many industrial peers.
- Balance-sheet premium: P/B of 3.12 shows investors pay a premium for intangible value, growth prospects, or returns on capital above book metrics.
- Investment implication: The divergence between trailing and forward P/E, combined with moderate EV multiples, can indicate undervaluation if forward earnings materialize as expected.
Nanning Chemical Industry Co., Ltd. (600301.SS) - Risk Factors
Nanning Chemical Industry Co., Ltd. (600301.SS) faces multiple material risks that investors should weigh alongside financial metrics and market positioning. The following discusses principal exposures, quantified where possible, and highlights potential impacts on cash flow, margins, compliance costs and reputation.
- Domestic concentration: ~85% of revenue is generated within China, while only 15% is attributed to international sales, limiting diversification of demand and foreign-currency revenue streams.
- Raw material dependence: Approximately 60% of total operating costs are tied to feedstocks such as ethylene and propylene, leaving profitability highly sensitive to commodity price swings.
- Regulatory & environmental compliance: In 2023, reports indicated ~30% of the company's facilities did not meet required emission standards, generating negative media coverage and elevating the risk of fines, shutdowns or remediation costs.
- Cyclical demand: Industry-wide profitability margins for comparable chemical producers have fluctuated between 5% and 12% over the past four years, implying earnings volatility for Nanning Chemical aligned with market cycles.
- Regional regulatory burdens: Potential regulatory challenges across jurisdictions can be costly - compliance costs in the EU may reach up to €1,000,000 per facility annually if operating or exporting there.
- Reputation & market access: Environmental concerns and compliance issues can erode customer trust, restrict access to premium markets, and increase working capital or capital expenditure requirements.
Financial sensitivity examples (illustrative based on the stated exposures):
| Metric | Baseline | Stress (commodity price +20%) | Impact on EBIT margin |
|---|---|---|---|
| Revenue split (Domestic / Intl) | 85% / 15% | 85% / 15% | Limited offset from FX or overseas demand |
| Operating cost tied to feedstocks | 60% of Opex | ~72% of Opex (if prices +20%) | EBIT margin falls toward lower end of 5%-12% range |
| Non-compliant facilities (2023) | 30% of facilities | Remediation / fines scenario | One-time capex and potential revenue disruption |
| EU compliance cost (per facility) | - | €1,000,000 annual | Reduces free cash flow if exporting or operating in EU |
- Cash flow & margin volatility: Given the 60% feedstock exposure and cyclical margin history (5%-12%), a sustained commodity upswing could compress margins and constrain free cash flow for dividends or deleveraging.
- Operational risk concentration: With nearly one-third of facilities flagged for emissions non-compliance in 2023, the company faces elevated short-term operational disruption and medium-term capital expenditure to remediate.
- Geographic & market risk: The 85% domestic revenue concentration increases sensitivity to Chinese economic cycles, domestic regulatory tightening, and local demand shocks.
Key scenarios investors should model:
- Commodity shock: +20% ethylene/propylene prices - estimate margin compression to ~5% and potential EBITDA decline of 15-25%.
- Environmental remediation: Remediating 30% non-compliant facilities - one-time capex and lost production days could reduce next-year EBITDA by an estimated 5-10% depending on remediation speed.
- EU expansion or export push: If exporting more to EU, expect incremental compliance costs up to €1M per facility annually - include this in SG&A and cash-flow forecasts.
For investor context on ownership and who's buying, see: Exploring Nanning Chemical Industry Co., Ltd. Investor Profile: Who's Buying and Why?
Nanning Chemical Industry Co., Ltd. (600301.SS) - Growth Opportunities
Nanning Chemical Industry sits at the intersection of structural market growth and industry-specific tailwinds. Key addressable markets and strategic levers suggest multiple avenues for revenue expansion, margin improvement and portfolio diversification over the next 3-7 years.- Global sustainable chemicals market: expected to reach $1 trillion by 2030 (CAGR ~11% from 2021-2030), presenting opportunities to launch higher-value eco-friendly products.
- Asia Pacific chemical sector: projected CAGR ~7.5% through 2028, supporting regional expansion and increased local demand for intermediates and specialty products.
- Specialty chemicals: forecasted to have ~ $1 trillion valuation by 2025, offering higher-margin end markets (electronics, automotive, agriculture).
- M&A environment: chemicals sector deals totaled ~$112 billion in 2022, creating inorganic growth paths for product and capability acquisition.
- Operational efficiency gains: targeted investments in technology could yield ~15-20% improvements in throughput, yield, and quality.
| Opportunity | Market/Metric | Estimated Impact on Nanning Chemical | Timeframe |
|---|---|---|---|
| Sustainable chemicals product line | Global market: $1T by 2030 (11% CAGR) | Revenue upside: potential +8-15% vs. baseline over 5 years | 2025-2030 |
| Asia Pacific expansion | APAC chemical CAGR ~7.5% through 2028 | Volume growth: +5-10% CAGR in regional sales | 2024-2028 |
| Specialty chemicals focus | Specialty market: ~$1T by 2025 | Gross margin improvement: +200-800 bps (depending on product mix) | 2024-2026 |
| Technology & automation | OpEx/Throughput | Operational efficiency gains: ~15-20% (lower unit costs, higher yields) | Rollout within 2-4 years |
| M&A / portfolio diversification | Sector M&A: $112B in 2022 | Accelerated market access and new chemistries; potential accretive acquisitions | Ongoing; opportunistic 1-3 year horizon |
- Product development: prioritize eco-friendly intermediates and specialty additives aimed at electronics and automotive supply chains.
- Capacity & capex: phased capacity additions aligned with demand signals in APAC to avoid cyclical overcapacity.
- Tech adoption: invest in process digitalization, advanced catalysts, and continuous manufacturing to target the 15-20% efficiency range.
- M&A criteria: target bolt-on specialty players with high margins, customer contracts in premium end-markets, or proprietary chemistries.
- ESG positioning: certify sustainable product lines and disclose life-cycle data to capture premium pricing and regulatory alignment.

Nanning Chemical Industry Co., Ltd. (600301.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.